Search Immortality Topics:

Page 21234..1020..»

Duke University Medical School – Anatomy

Posted: February 20, 2019 at 8:47 am

Date

Pre-lab exercise

Introduction

Lab 1

Wed, Sep 19

Lab 2

Fri, Sep 21

Lab 3

Mon, Sep 24

Lab 3 Pre-lab video

Laminectomy video

Lab 4

Mon, Oct 1

TBE

Wed, Oct 3

Lab 5

Fri, Oct 5

EXAM 1

MON, OCT 8

Lab 6

Wed, Oct 10

Lab 7

Mon, Oct 15

Lab 8

Lab 9

Wed, Oct 24

Lab 9 pre-lab video

Perineum video

Lab 10

Fri, Oct 26

EXAM 2

MON, OCT 29

Lecture: Abdomen and Pelvis / GI and UG Embryology; Lab: Abdomen and Pelvis

Lab 11

Wed, Oct 31

Lab 12

Fri, Nov 2

Lab 13

Mon, Nov 5

Lab 14

Wed, Nov 7

Lab 15

Fri, Nov 9

Lab 16

Mon, Nov 12

TBE

Wed, Nov 14

Lab 17

Wed, Nov 14

EXAM 3

Fri, Nov 16

Lab 18

Fri, Nov 16

Lab 18 pre-lab video

Skull Osteology Video

Lab 19

Mon, Nov 19

Lab 20

Mon, Nov 26

Lab 21

Wed, Nov 28

Lab 22

Fri, Nov 30

Mastication and Infratemporal Fossa I

Lab 23

Mon, Dec 3

Mastication and Infratemporal Fossa 2

TBE 5

Wed, Dec 5

Lab 24

Wed, Dec 5

Lab 24 pre-lab video

Larynx video

Lab 25

Wed, Dec 7

EXAM 4

FRI, DEC 14

Click here to submit questions or comments about this site.

Follow this link:
Duke University Medical School - Anatomy

Recommendation and review posted by G. Smith

Regenerative Medicine | Swedish Medical Center Seattle and …

Posted: February 18, 2019 at 9:47 pm

Regenerative medicine (platelet rich plasma, stem cell treatment and tenex) is a non-surgical and natural treatment to stimulate and enhance healing of injuries, such as osteoarthritis, tendinitis, plantar fasciitis, and degenerative musculoskeletal diseases.

Most simply defined, PRP is a platelet count above normal. Platelets are your bodys natural healing particles. When you get an injury, platelets in your blood go to the area of injury. Your platelets release growth factors (programming signals) that tell your brain you have an injury and what type of stem cells to send to the area so you get an appropriate healing response. Once concentrated out of a larger volume of blood, PRP can be injected under ultrasound guidance into the injured area to stimulate and enhance healing. PRP has been shown to be beneficial on conditions such as tendinitis/tendinosis, tendon tears, ligament sprains/tears, muscle tears, and osteoarthritis/ joint pain. PRP can also be used in the spine, where the injections are placed using x-ray guidance after careful confirmation that those structures are indeed the source of pain.

This process involves harvesting your stem cells from your bone marrow in your pelvis and concentrating the stem cells by processing the bone marrow in a specialized centrifuge. After first numbing the area so it isnt painful, a needle is used to withdraw bone marrow from your posterior iliac crest (lower back area). This is the same procedure performed for over 50 years in hematology offices. Special centrifuges are then used to spin the bone marrow and separate out and concentrate the stem cells. The stem cells are then activated with platelet rich plasma (PRP) and injected under ultrasound guidance into damaged tissue or joints. Some of the most common applications of stem cell treatments are for osteoarthritis, avascular necrosis, tendon and ligament sprains/tears, tendinitis/tendinosis labral tears, and muscle tears. Stem cells can also be used in the spine, where the injections are placed using x-ray guidance after careful confirmation that those structures are indeed the source of pain.

Recently, percutaneous ultrasonic tenotomy (UT) has evolved as a potential minimally invasive treatment for tendinopathy. This has been performed at Swedish sports medicine since 2014. It is a novel technique in which phacoemulsification (sound waves) are used to debride (clean up) and aspirate bad tendon tissue through a small incision via a small handpiece. Studies have shown it to be safe and effective at treating tendinopathies in multiple different tendons, including documentation of success in treatment of plantar fasciopathy after previous release. It is most commonly used on Achilles tendinitis, lateral epicondylitis (tennis elbow), medial epicondylitis (golfers elbow), plantar fasciitis/ plantar fascial rupture, patellar tendinitis, quadriceps tendinitis, calcific tendinitis of the shoulder, gluteal tendinitis, and hamstring tendinitis.

Read the original:
Regenerative Medicine | Swedish Medical Center Seattle and ...

Recommendation and review posted by G. Smith

Global Regenerative Medicine Market Analysis & Forecast to …

Posted: February 18, 2019 at 9:46 pm

NEW YORK, Feb. 14, 2019 /PRNewswire/ -- This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth $28 billion in 2018 and will grow to over $81 billion by 2023, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry will grow significantly at a CAGR of over x% and reach $x billion by 2023. Tissue engineering is forecast to grow at a CAGR of x% to 2023 and potentially reach $x billion. This report describes the evolution of such a huge market in 15 chapters supported by over 350 tables and figures in 700 pages.

Read the full report: https://www.reportlinker.com/p04876076

An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies. Global regenerative medicine market, global breakdown, application breakdown and leading market players Detailed account of the stem cell industry market by geography, indication and company profiles Profiles, marketed/pipeline products, financial analysis and business strategy of the major companies in this space Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for regenerative medicine Insight into the challenges faced by stakeholders, particularly about the success vs. failure ratios in developing regenerative medicine drugs and therapies. Insight into the biobanking industry globally and its impact on the overall market Description and data for the prevalence of disease types that are addressed by regenerative medicine, stem cells, tissue engineering and CAR-T therapies Financial market forecast through 2023 with CAGR values of all market segments outlined in the objective SWOT analysis of the global market Geographical analysis and challenges within key topographies including the USA, Japan, South Korea, China and Europe

Key Questions Answered

What is the global market for regenerative medicine from 2017 to 2023? What is the global market for regenerative medicine by geography, through 2023? What is the global market for regenerative medicine by indication, through 2023? What is the global market for the stem cell industry from 2017 to 2023? What is the global market for the stem cell industry by geography, through 2023? What is the global market for the stem cell industry by indication, through 2023? What disruptive technology is advancing the overall regenerative medicine market? What are the major company players in the regenerative medicine, stem cells, tissue engineering and CAR-T industries? What types of clinical trials are currently being performed by stakeholders and major players? What are the strengths, weaknesses, opportunities and threats to the market? Which geographic markets are dominating the space? What are the advantages and disadvantages of the allogenic and autologous stem cell industry? What are the main driving forces of this space? What are the main restraints of the regenerative medicine industry as a whole? What is the current environment of the global cord blood bank industry? What are the global access challenges of the regenerative medicine market? What is the space like in Japan, China, South Korea, USA and Europe? What are the main challenges associated with CAR T therapy? When will the first CAR T therapeutics be approved? What are the current regulations for immunotherapies in USA, Europe & Japan? What are the main manufacturing steps in CAR T therapy? What challenges lie ahead for CAR T production?

Countries Covered Global, USA, Europe, UK, Japan, South Korea, Singapore, Asia/Pacific, ROC

Executive Summary

Regenerative medicine's main objective is to heal and replace organs/cells that have been damaged by age, trauma or disease. Congenital defects can also be addressed with regenerative medicine. Therefore, it's market encompasses dermal wounds, cardiovascular disease, specific cancer types and organ replacement. To that end, regenerative medicine is a broader field and manipulates the body's immune system and regeneration potential to achieve its requirement. Financially speaking, investment into this space is dominated by grants, private investors and publicly traded stocks. Looking forward, the regenerative medicine market is promising for a number of robust reasons including:

Increasing number of potentially successful clinical trials Increasing number of mergers and acquisitions High unmet need in many indications Global penetration, especially in Japan will boost the market

Of course restrictions to this market include strict regulations in certain geographies, and also the level of investment required to support R&D, clinical research, trials and commercialization. Reimbursement strategies are also paramount to success of the overall space.

There are over 700 regenerative medicine companies globally at present, that all together have a $x billion market cap. At present the total regenerative medicine market has more than 500 products commercialized. The regenerative medicine market encompasses a number of key technology submarkets including: Cell therapy including stem cells Tissue Engineering Biomaterials BioBanking

Reconstructive surgeries for bones and joints is the mainstay of the regenerative medicine market. Geographically speaking, due to the dominance of the bone and joint reconstruction market, the US has the biggest space. This is followed by Europe. However, due to recent positive legislation in Japan and Europe, the stem cell arena will grow more substantially in these regions over the next five years. By 2023, it is possible that Europe will surpass the US market with respect to stem cell applications, and this will become more likely if the Trump Administration restricts legislation and funding.

Market Applications & Opportunities for Regenerative TherapiesRegenerative medicine, including cellular and gene therapies will have a significant impact on the expenditure of payers, once reimbursement schemes are optimized. To that end a number of conditions that regenerative medicine tackles is synonymous with an aging population such as Cardiovascular diseases & stroke Diabetes Inflammatory and immune diseases Wound healing and soft tissue regeneration Neurodegenerative diseases e.g., ALS, Alzheimer's and Parkinson's Spinal cord injury Musculoskeletal disorders Ocular disease

Global Financial LandscapeThe last few years have been busy for regeneration medicine, cellular therapeutics and the gene therapy industry, with high investment from pharma giants such as Eli Lilly, BMS, Astra Zeneca and Sanofi. Company partnerships were also in motion that included Kite Pharma and Bluebird/Five Prime, Juno and Fate Therapeutics/ Editas Medicine. One of the highlights was the $x billion, four year deal between CRISPR Technologies and Vertex which indicated that gene editing technologies are cutting edge.

Stem Cell Market Analysis & Forecast to 2023Today the stem cell and regenerative medicine industries are interlinked and over the last number of years have grown substantially. Regenerative medicine replaces or regenerates cells, tissues or organs and in order to achieve this uses produces from the pharmaceutical, biologics, medical device and cell therapy spaces. Therefore, cell therapy, and stem cells come under the umbrella market of regenerative medicine. Cell therapy is a platform by which regenerative medicine can achieve its aim and concentrates on using cells as therapeutics to treat disease. In 2018, the global stem cell market was worth $x billion globally, and this is set to rise to $x billion by 2023 with a CAGR of x%.

Tissue Engineering Market Analysis and Forecast to 2023Tissue engineering was the forerunner of the present regenerative medicine market. The area of biomaterials was developed to use cells and biological material and incorporate them into scaffolds and functional tissues. Some of the main applications of tissue engineered products include artificial skin and cartilage and so this area dominates the dermatology, bone and joint submarket. Wound repair is also a significant area for tissue engineering, with products such as Dermagraft in the market.

The global market for tissue engineering was estimated at $x billion in 2018 by Kelly Scientific analysis. It is forecast to grow at a CAGR of x% to 2023 and potentially reach $x billion. Tissue engineering is being driven by the increase in technology of biomaterials, bioscaffolds and bio 3D printing. The rise in the amount of orthopedic transplantations is demanding the market to produce more innovative solutions such as 3D printed organs. In the long term future, Kelly Scientific forecasts the advance of cutting edge 3D bioprinters in this market place

Biobanking Market AnalysisThe biobanking industry is made up of over 500 public and private blood banks globally. These companies and institutions collect, store and distribute adipose tissue, cord blood and birth tissues, musculoskeletal tissues, pericardium, skin, bone, vascular tissue, autologous and allogeneic cells and other biological samples. They operate by charging a collection fee and then a storage fee, which is usually operational for 20 years. Private banking costs between $1,350 to $2,300 as an initial fee, and then between $100 to $175 per annum for storage. Public banking is free, and a number of hybrid models have been introduced in Europe and Asia to date.

CAR-T IndustryThe CAR-T industry is addressing unmet needs in specific relapsed cancers, however does early clinical trial data support a blockbuster status for this upcoming therapy? Some patients do indeed show long term activity and high remission rates, but there is a large proportion of patients with toxicities such as cytokine release syndrome and neurotoxicity. The main players within the CAR-T market are Juno Therapeutics, Kite Pharma, Novartis and Cellectis. The market is moving ahead, backed by years of R&D, from both academia and industry, investors capitol and small clinical studies. From 2017, Kelly Scientific forecasts that CAR T therapy will become more streamlined, with faster manufacturing times as advances in technologies take hold and clinical trials provide more robust evidence that this immunotherapy is robust. These factors, plus strategies to reduce adverse reactions and toxicities and larger players like Novartis taking stage will push CAR T therapy ahead. However, recent deaths in the Juno ROCKET trial are creating questions amongst investors. How will the CAR T space influence the total immunotherapy industry going forward? This comprehensive report scrutinizes the total market and provides cutting-edge insights and analysis.

Read the full report: https://www.reportlinker.com/p04876076

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

Story continues

More here:
Global Regenerative Medicine Market Analysis & Forecast to ...

Recommendation and review posted by G. Smith

Futurism – the-artists.org

Posted: February 18, 2019 at 2:45 am

Futurism is an early 20th-century artistic movement that centered in Italy and emphasized the dynamism, speed, energy, and power of a machine, as well as the vitality, change, and restlessness of modern life in general. The most significant results of this movement were in visual arts and poetry.

Referred to as an avant-garde movement then, Futurism was established in 1909 in Milan by Flippo Tommaso Marinetti, an Italian poet. Marinetti officially launched Futurism through his masterpiece entitled Futurist Manifesto published in La Gazzetta dellEmilia on February 5, 1909. Not long after, many modern artists, painters, and composers joined him1, forming small art galleries in reverence to the newly established movement.

However, the evolution of style and subject of Futurism was rather slow. It took almost two years to develop Giovani Segantinis Divisionism technique, a Futurism technique which uses colors and breaking lights into a field of stippled stripes and dots.2 It also took some time before the artistic concepts of Futurism were applied to architecture, furniture, literature, film, music, and a range of other art forms.

Futurism has influenced many succeeding art movements in the 20th century. Art Deco, Dada, Constructivism, Vorticism, Cubism, and Surrealism are among the ones that are closely associated to it. Eventually, Futurism also evolved into Neo-Futurism, which an art movement that is driven by modern technology.

An art gallery featuring interesting Futurism artworks will most likely seem to glorify the days new technologies. This is why the common subject is oftentimes automobiles. And such a collection is clearly in pure contrast with the cultural traditions preserved by a number of museums and art galleries. Even so, there are hundreds of very notable Futurism artworks on display in art galleries all over the world, made by modern artists. Some of the famous examples of Futurism artworks are Giacomo Ballas Abstract Speed + Sound (1913), Umberto Boccionis The City Rises (1910), and Natalia Goncharovas Cyclist (1913).

The chief modern artists of futurism include Umberto Boccioni, Giacomo Balla, Gino Severini, Carlo Carra, and Luigi Russolo. However, even famed artists like Pablo Picasso and Christopher R.W. Nevinson has artworks that are closely identified with the artistic elements of Futurism. Many art galleries take pride in featuring Futurism artists, which list also includes Italian artist Anton Giulio Bragaglia, Russian painter David Burliuk, Bulgarian designer Nikolay Diulgheroff, Turkish poet Nazim Hikmet, and Portuguese novelist Almada Negreiros, among others.

1http://www.britannica.com/EBchecked/topic/222921/Futurism

2http://en.wikipedia.org/wiki/Futurism#Italian_Futurism

manifestosFuturism was an international art movement founded in Italy in 1909. It was (and is) a refreshing contrast to the weepy sentimentalism of Romanticism. The Futurists loved speed, noise, machines, pollution, and cities; they embraced the exciting new world that was then upon them rather than hypocritically enjoying the modern worlds comforts while loudly denouncing the forces that made them possible. Fearing and attacking technology has become almost second nature to many people today; the Futurist manifestos show us an alternative philosophyrussian avant gardePainters, poets and writers.Guggenheim: Futurismn a stylistic idiom that integrated some of the techniques of Cubism [more] and Divisionism, the Futurists glorified the energy and speed of modern life together with the dynamism and violence of the new technological society. In their manifestos, art, poetry, and theatrical events, they celebrated automobiles, airplanes, machine guns, and other phenomena that they associated with modernity; they denounced moralism and feminism, as well as museums and libraries, which they considered static institutions of an obsolete culture

Read the original post:
Futurism - the-artists.org

Recommendation and review posted by G. Smith

Pharma Conferences|Pharmaceutical Conferences|IPSDD 2019 …

Posted: February 17, 2019 at 12:45 pm

Innovation info conferences (IIC) is an international conference organizer which has an attracting global participants intent on sharing, exchanging and exploring new avenues of pharmaceutical research, latest innovations and developments. Innovation Info Conferences aims to gather reputed plenary speakers, keynote speakers, invited speakers and fresh contributed featured speakers, young researchers, exhibiting companies and students.

Innovation Info Conferences is glad to announce the International Conference and Exhibition on Pharmaceutical Sciences and Drug Development (IPSDD 2019) be held during Novemberin Hong Kong, China.

Innovation info conferences (IIC) intends to provide a valuable platform for scientific discussions as well as a stimulating meeting place encouraging a close partnership between delegates from academia and industry.

Developments, achievements and prospects in all fields of organometallic chemistry will be presented in plenary presentations by distinguished and by young scientists, keynote lectures, as oral communications and posters in various sections.

The aim of the IPSDD 2019 is to unravel the benefits and emerging applications through the presentations by top class researchers, chemical engineers and Industrial heads by discussing the latest developments and innovations in the fields of Chemical Engineering. We sincerely hope that IPSDD-2019 serves as an international platform for meeting researchers across the globe, widen professional boundaries and create new opportunities, including establishing new collaborations.

View original post here:
Pharma Conferences|Pharmaceutical Conferences|IPSDD 2019 ...

Recommendation and review posted by G. Smith

Integrative Medicine in Philadelphia Healing Arts Center …

Posted: February 16, 2019 at 10:47 am

Our Integrative Medicine Physician

Steven Rosenzweig, MD graduated from the University of Pennsylvania School of Medicine in 1986 and completed his residency training in Emergency Medicine at Jefferson University Hospital in 1989. He was a full-time Jefferson physician until 2007. During that time he served as the Founding Medical and Academic Director of the Thomas Jefferson University Center of Integrative Medicine, which opened its doors in 1998. In 2007 he established his independent, private practice in Integrative Medicine and also joined the teaching faculty of Drexel University College of Medicine.

Dr. Rosenzweig is Board Certified in Emergency Medicine and Palliative Medicine. He extended his medical training through the study of Anthroposophical Medicine, a European-based system of Integrative Medicine. He participated in professional training under the direction of Jon Kabat-Zinn, PhD, founder of the Stress Reduction Clinic at the University of Massachusetts Medical Center (UMMC), and has completed the Teacher Development Intensive in Mindfulness-Based Stress Reduction offered at the Stress Reduction Clinic at UMMC. He also completed Professional Certification Training in Interactive Guided Imagerysm through the Academy for Guided Imagery.

Dr. Rosenzweig is Clinical Associate Professor at Drexel University College of Medicine where he is Director of the Program in Medical Humanism and Professional Values in the Office of Educational Affairs. He directs courses in Bioethics, Community Service Learning and Professionalism. He teaches mindfulness and Integrative Medicine, and has been developing mind-body projects as part of the community service curriculum. He is also an Adjunct Associate Professor at Jefferson Medical College where he currently lectures on botanical medicine and racial disparities in healthcare. Dr.Rosenzweig is also a member of the medical staff of Hahnemann University Hospital and Abington Memorial Hospital.

View original post here:
Integrative Medicine in Philadelphia Healing Arts Center ...

Recommendation and review posted by G. Smith


Page 21234..1020..»